Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Details
Original language | English |
---|---|
Pages (from-to) | 2520-2525 |
Number of pages | 6 |
Journal | Haematologica |
Volume | 108 |
Issue number | 9 |
Publication status | Published - 1 Sept 2023 |
Peer-reviewed | Yes |
External IDs
PubMedCentral | PMC10483343 |
---|---|
Scopus | 85170112378 |
Keywords
Keywords
- Humans, Staurosporine/therapeutic use, Leukemia, Myeloid, Acute/drug therapy, Mutation, fms-Like Tyrosine Kinase 3/genetics